Literature DB >> 8364867

Epidermotropic metastatic melanoma. Are the current histologic criteria adequate to differentiate primary from metastatic melanoma?

M P Bengoechea-Beeby1, A Velasco-Osés, F Mouriño Fernández, M C Reguilón-Rivero, L Remón-Garijo, C Casado-Pérez.   

Abstract

A case is reported of a patient with a lentiginous acral melanoma of the heel that was excised and recurred 3 years later at the margin of the previous scar. After another 3 years, a group of five small lesions appeared in the thigh that were considered to be junctional and epidermotropic metastases. The authors question the current histologic criteria for differentiating junctional and epidermotropic metastases of previous melanomas from multiple primary melanomas. It is concluded that the clinical history is of primary importance in reaching a correct diagnosis; histologic studies are not sufficient.

Entities:  

Mesh:

Year:  1993        PMID: 8364867     DOI: 10.1002/1097-0142(19930915)72:6<1909::aid-cncr2820720619>3.0.co;2-s

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Epidermotropic metastatic melanoma clinically resembling agminated spitz nevi.

Authors:  Hee Joo Kim; Byoung Joon So; Min Gun You; Il-Hwan Kim
Journal:  Ann Dermatol       Date:  2014-09-26       Impact factor: 1.444

2.  Evaluation of the clonal origin of multiple primary melanomas using molecular profiling.

Authors:  Irene Orlow; Diana V Tommasi; Bradley Bloom; Irina Ostrovnaya; Javier Cotignola; Urvi Mujumdar; Klaus J Busam; Achim A Jungbluth; Richard A Scolyer; John F Thompson; Bruce K Armstrong; Marianne Berwick; Nancy E Thomas; Colin B Begg
Journal:  J Invest Dermatol       Date:  2009-03-12       Impact factor: 8.551

3.  Epidermotropic metastatic melanoma with perilesional depigmentation in an Indian male.

Authors:  Bhavana Doshi; Sunanda Mahajan; Uday S Khopkar; Vidya Kharkar; Prachi Agarwal
Journal:  Indian J Dermatol       Date:  2013-09       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.